Millennium Management’s Minerva Surgical UTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-945
Closed -$3.11K – 6854
2023
Q3
$3.11K Sell
945
-3,278
-78% -$14.9K ﹤0.01% 5934
2023
Q2
$21.6K Buy
4,223
+2,159
+105% +$10.6K ﹤0.01% 5616
2023
Q1
$9K Buy
+2,064
New +$12.7K ﹤0.01% 6051
2022
Q1
– Sell
-1,302
Closed -$134K – 7772
2021
Q4
$134K Buy
+1,302
New +$185K ﹤0.01% 6128

Millennium Management's UTRS Position: Q4 2023 in Review

Millennium Management sold out of Minerva Surgical (UTRS) in Q4 2023, closing a stake of 945 shares — an estimated $3.11K sold.

Millennium Management first reported a position in UTRS in Q4 2021 and held it in 4 quarters. The position peaked at $134K in Q4 2021. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

  • Millennium Management reported no remaining Minerva Surgical position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 945 Minerva Surgical shares in Q4 2023, an estimated $3.11K.
  • Millennium Management first reported a position in Minerva Surgical in Q4 2021 and held it in 4 quarters.
  • Millennium Management's Minerva Surgical position peaked at $134K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Minerva Surgical as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.